Sagimet Biosciences Prices $175M Equity Offering, Shares Rise 30%
Sagimet Biosciences (SGMT) shares surged approximately 30% pre-market following the pricing of a $175 million equity offering. The company issued ~29 million shares at $6.00 per share, with gross proceeds expected to be used for general corporate purposes.
Tickers: $SGMT
Topics: biopharmaceutical equity raise funding stock offering